Mycoplasma pneumonia risk factors

Jump to navigation Jump to search

Pneumonia Main Page

Mycoplasma pneumonia Microchapters


Patient Information


Historical Perspective



Differentiating Mycoplasma pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis


History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray



Medical Therapy


Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mycoplasma pneumonia risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Mycoplasma pneumonia risk factors

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mycoplasma pneumonia risk factors

CDC on Mycoplasma pneumonia risk factors

Mycoplasma pneumonia risk factors in the news

Blogs on Mycoplasma pneumonia risk factors

Directions to Hospitals Treating Mycoplasma pneumonia

Risk calculators and risk factors for Mycoplasma pneumonia risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Risk factors in the development of Mycoplasma pneumonia include age between 5-40 years, living in closed communities (healthcare settings, prisoners, military, college students), active lung disease, immunocompromised status, history of sickle cell disease, active smoking, and living in regions with temperate climates.

Risk Factors

Risk factors in the development of Mycoplasma pneumonia include the following:

  • Individuals between 5 and 40 years of age
  • Mycoplasma pneumonia is less common (but still incident) among children < 5 years of age or adults > 40-60 years of age.
  • Elderly individuals are at increased risk of developing Mycoplasma pneumonia-related complications.
  • Individuals in closed communities
  • Healthcare setting
  • Prisoners
  • Military
  • College dormitories
  • Active smoking status
  • Active lung disease
  • Patients with sickle cell disease
  • Immunocompromised status
  • Living in regions with temperate climates (especially during Summer and Fall)